- 작성자 : ILIAS Biologics
- 작성일 : 20-12-02 17:38
- 조회 : 357회
30 November 2020
ILIAS Biologics won an award at the 2020 BioChallenge
On November 30th, ILIAS Biologics received the ‘Cytiva Korea CEO Award' at the 2020 BioChallenge. The 2020 BioChallenge, hosted by Maeil Business News Korea, sponsored by Cytiva(formerly GE Healthcare Life Sciences), selected the seven promising Korean biotech and pharmaceutical companies.
ILIAS is entitled to receive (1) APAC Fast Trak Training and (2) products for cell culture and purification worth up to 150 million Korean won as the benefit of the award. ILIAS will accelerate its scaled-up manufacturing process development of exosome-based therapeutics with this benefit and support.
Please find the link below for more information.